A1 Refereed original research article in a scientific journal

LimROTS: A Hybrid Method Integrating Empirical Bayes and Reproducibility-Optimized Statistics for Robust Differential Expression Analysis




AuthorsAnwara, Ali Mostafa; Jeba, Akewak; Lahti, Leo; Coffey, Eleanor

EditorsBirol Inanc

PublisherOxford University Press (OUP)

Publication year2025

Journal:Bioinformatics

Article numberbtaf570

ISSN1367-4803

eISSN1367-4811

DOIhttps://doi.org/10.1093/bioinformatics/btaf570

Web address https://doi.org/10.1093/bioinformatics/btaf570

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/504717932


Abstract

Motivation

Differential expression analysis plays a vital role in omics research enabling precise identification of features that associate with different phenotypes. This process is critical for uncovering biological differences between conditions, such as disease versus healthy states. In proteomics, several statistical methods have been used, ranging from simple t-tests to more advanced methods like DEqMS, limma and ROTS. However, a flexible method for reproducibility-optimized statistics tailored for clinical omics data has been lacking.

Results

In this study, we developed LimROTS, a hybrid method that integrates a linear regression model and the empirical Bayes approach with the Reproducibility-Optimized Statistics, to create a novel moderated ranking statistic, for robust and flexible analysis of proteomics data. We validated its performance using twenty-one proteomics gold standard spike-in datasets with different protein mixtures, MS instruments, and techniques for benchmarking. This hybrid approach improves accuracy and reproducibility of complex proteomics data, making LimROTS a powerful tool for high-dimensional omics data analysis.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This project has received funding from, the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952914 / FindingPheno (to LL). The Michael J. Fox Foundation grants MJFF-021587, MJFF-023714, and ERANET (Research Council of Finland 334776) to EC. The ImmuDocs doctoral program award to AMA.


Last updated on 2025-20-10 at 11:30